Pages Tagged with "Research Multiple Myeloma"

Three ways City of Hope is closing the cancer care gap
Expanding Our Reach In 2022, City of Hope expanded our reach nationally by acquiring Cancer Treatment Centers of America (CTCA), a network of oncology hospitals and outpatient care centers...
City of Hope researchers present innovative studies at American Society of Hematology meeting
Doctors and scientists from City of Hope presented data on potential new treatment options for hematological cancers and a way to predict disease outcomes in patients with diffuse large B-cell...
City of Hope opens first multiple myeloma autologous CAR T cell therapy trial targeting CS1 protein on cancer cells
CONTACT Letisia Marquez 626-218-3398lemarquez@coh.org   City of Hope will manufacture CAR T cells in its own laboratories   DUARTE, Calif. — City of Hope is now enrolling patients with...
Targeting multiple myeloma in black communities
Last fall, City of Hope scientists opened a clinical trial investigating the use of the arthritis drug leflunomide as an innovative treatment for cancer patients with COVID-19. Now, thanks to a...
How innovations in multiple myeloma care result in superior national survival outcomes
City of Hope’s dedication to innovative research and groundbreaking advancements in the field of cancer over our 100-year history has resulted in measurable outcomes for our patients. With one of...
Subscribe to Research Multiple Myeloma